Clinical Trial Update: The Efficacy, Safety, and Tolerability of Probiotics on the Mood and Cognition of Depressed Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating probiotics for mood and cognition in patients with major depressive disorder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Queen's University | Conditions: Major Depressive Disorder, Depression | Phase 3 | Status: COMPLETED